Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.
Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.
Filter by Form Type:
Industry:Biotechnologyβ
2026-06-12PALI3Power of Attorney for Jordan Michael Zwick
This filing is an Exhibit 24, a Power of Attorney document for Jordan Michael Zwick, a Section 16 reporting person for Palisade Bio Inc. (PALI). Mr. Zwick designates John David Finley and Ryker Willie as his attorneys-in-fact to complete and execute all necessary Forms 3, 4, and 5, along with any other required documen...
Small CapBiotechnology
2026-06-11ABCL3Power of Attorney for SEC FilingsMEDIUM
This filing details a Power of Attorney granted by Victor Sandor, a director of AbCellera Biologics Inc., to Tryn Stimart. Ms. Stimart, as Chief Legal and Compliance Officer, is authorized to execute various U.S. Securities and Exchange Commission (SEC) forms on behalf of Mr. Sandor. These forms include Form ID, Form 3...
Small CapBiotechnology
2026-06-11ALDX3Insider Transaction Report for Darlene M. Deptula-Hicks
This filing is an initial report (Form 3) for Darlene M. Deptula-Hicks, a director at Aldeyra Therapeutics, Inc. (ALDX). The report details her ownership as of June 9, 2026. Ms. Deptula-Hicks is identified as a director and not an officer or 10% owner. The filing indicates no securities were owned by the reporting pers...
Micro CapBiotechnology
2026-06-11CUE3Form 3 Filing for Cue Biopharma, Inc. - Initial Statement of Beneficial OwnershipMEDIUM
This filing reports on Form 3, an Initial Statement of Beneficial Ownership, for Sumita Ray, identified as a corporate secretary and Chief Legal Compliance Officer of Cue Biopharma, Inc. (CUE). The report details holdings as of June 1, 2026. Ray beneficially owns 54,589 shares of Common Stock directly. Additionally, Ra...
Micro CapBiotechnology
2026-06-11CUE3Form 3 Filing for Michael Vincent Meluzio at Cue Biopharma, Inc.
This filing is a Form 3, which reports initial beneficial ownership of securities. Michael Vincent Meluzio, identified by CIK 0002138368, is the reporting owner. He is the VP, Principal Accounting Officer of Cue Biopharma, Inc. (CIK 0001645460, trading symbol CUE). The filing indicates he owns 1 security. The report of...
Micro CapBiotechnology
2026-06-11Aldeyra Therapeutics, Inc.3Insider Transaction Report for Darlene M. Deptula-HicksDuplicate
This filing is an initial report (Form 3) for Darlene M. Deptula-Hicks, a director at Aldeyra Therapeutics, Inc. (ALDX). The report details her ownership as of June 9, 2026. Ms. Deptula-Hicks is identified as a director and not an officer or 10% owner. The filing indicates no securities were owned by the reporting pers...
Micro CapBiotechnology